- Home
- AZN vs PM Comparison
AZN vs PM Comparison
Compare AZN & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- PM
- Stock Information
- Founded
- AZN 1992
- PM 1987
- Country
- AZN United Kingdom
- PM United States
- Employees
- AZN N/A
- PM N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- PM Medicinal Chemicals and Botanical Products
- Sector
- AZN Health Care
- PM Health Care
- Exchange
- AZN Nasdaq
- PM Nasdaq
- Market Cap
- AZN 212.2B
- PM 203.7B
- IPO Year
- AZN 1993
- PM N/A
- Fundamental
- Price
- AZN $65.35
- PM $124.21
- Analyst Decision
- AZN Buy
- PM Buy
- Analyst Count
- AZN 10
- PM 12
- Target Price
- AZN $88.80
- PM $127.86
- AVG Volume (30 Days)
- AZN 5.6M
- PM 5.0M
- Earning Date
- AZN 02-06-2025
- PM 02-06-2025
- Dividend Yield
- AZN 2.27%
- PM 4.35%
- EPS Growth
- AZN 9.79
- PM 22.34
- EPS
- AZN 4.15
- PM 6.30
- Revenue
- AZN $51,206,000,000.00
- PM $37,219,000,000.00
- Revenue This Year
- AZN $17.69
- PM $10.34
- Revenue Next Year
- AZN $7.95
- PM $6.21
- P/E Ratio
- AZN $30.78
- PM $19.72
- Revenue Growth
- AZN 13.81
- PM 8.58
- 52 Week Low
- AZN $60.47
- PM $87.82
- 52 Week High
- AZN $87.68
- PM $134.15
- Technical
- Relative Strength Index (RSI)
- AZN 41.89
- PM 40.71
- Support Level
- AZN $66.14
- PM $122.04
- Resistance Level
- AZN $67.47
- PM $129.75
- Average True Range (ATR)
- AZN 0.93
- PM 2.13
- MACD
- AZN -0.03
- PM -0.85
- Stochastic Oscillator
- AZN 30.45
- PM 19.44
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heatsticks.